Articles By Nushin Rashidian
US cannabis consumers and patients are asking questions like: will my local shop close? Will delivery be an option? Cannabis Wire is tracking cannabis regulators’ announcements.
Several states were tackling medical or adult use legalization bills before the COVID-19 pandemic hit. Cannabis Wire reached out to key lawmakers to learn the latest.
In 2016, the US Drug Enforcement Administration said it would, for the first time, open applications for those hoping to become federally-licensed cannabis researchers. The details came four years later.
Cannabis Wire spoke with the CDC’s National Institute for Occupational Safety and Health about the emerging cannabis industry and its workers.
The FDA is reopening public comment, collaborating with global regulators on how to handle cannabinoids, and backing research on CBD and “dermal penetration.”
A global vote this week on the WHO’s position will be delayed. But here’s what the US (and other countries) have said so far.
Cannabis Wire reviewed a draft decision to delay until December the UN Commission on Narcotic Drugs vote on the World Health Organization’s recommendation to reschedule cannabis.
In a Q&A, the founder of one of the companies hoping for a federal license to supply researchers shares the frustrations of the process.
Despite vocal support from the governor, a Senate committee has tabled the Cannabis Regulation Act.